Thrombopénies induites par les héparines: nouveautés thérapeutiques

La Revue de medecine interne

Volumn 19, Issue 11, 1998, Pages 783-786

  Lecompte, T ^a   Maistre, E de ^a   Wahl, D ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

heparin; h parine; newer anticoagulants; nouveaux anticoagulants thrombocytopenia; thrombop nie

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; DANAPAROID; HEPARIN; HIRUDIN; INTERLEUKIN 8;

DRUG INDUCED DISEASE; EDITORIAL; HUMAN; RISK FACTOR; THROMBOCYTOPENIA; TREATMENT INDICATION; CHEMICALLY INDUCED DISORDER; NOTE;

ANTICOAGULANTS; HEPARIN; HUMANS; RISK FACTORS; THROMBOCYTOPENIA;

EID: 0032322260     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/S0248-8663(98)80381-0     Document Type: Editorial

References (15)

1. Lecompte T Stieljes N Shao-Kai L Morel MC Kaplan C Samama MM Heparin- and streptokinase-dependent platelet-activating immunoglobulin G: mechanism and diagnosis Semin Thromb Hemost 21 1995 95 105
2. Amiral J Wolf M Vissac A Meyer D Mécanismes moléculaires et cellulaires des thrombopénies induites par l'héparine Hématologie 2 1996 279 286
3. Pouplard C Amiral J Borg J Vissac A Delahousse B Gruel Y Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium Br J Haematol 99 1997 273 280
4. Arnout J The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia Thromb Haemost 75 1996 536 541
5. Warkentin T Chong B Greinacher A Heparin-induced thrombocytopenia: towards consensus [review article] Thromb Haemost 79 1998 1 7
6. Luzzatto G Cordiano I Patrassi G Fabris F Heparin-induced thrombocytopenia: discrepancy between the presence of IgG cross-reacting in vitro with Fraxiparine and its successful clinical use [Letter] Thromb Haemost 75 1996 211 212
7. Lecompte T Luo SK Stieltjes N Lecrubier C Samama MM Thrombocytopenia associated with low molecular weight heparin [Letter] Lancet 338 1991 1217
8. Magnani HN Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172) Thromb Haemost 70 1993 554 561
9. Magnani HN Orgaran (danaparoid sodium) use in the syndrome of heparin-induced thrombocytopenia Proceedings of a workshop held in London 1996 Platelets 8 1997 74 81
10. Chong B Low molecular weight heparinoid and heparin-induced thrombocytopenia [Abstract] Aust NZ J Med 26 1996 331
11. Schiele F Vuillemenot A Kramarz P Kieffer Y Anguenot T Bernard Y Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia Am J Haematol 50 1995 20 25
12. Gindre I de Maistre E Perrin A Lecompte T Hoffman M Thrombopénies sous héparinothérapie. Utilisation du danaparoïde (Orgaran), treize cas monocentriques sous le régime de l'ATU Thérapie 52 1997 591 597
13. Poullin P Pietri A Lefevre P Thrombopénie induite par l'héparine: régression rapide de la thrombopénie et de la thrombose après échange plasmatique. À propos d'un cas Rev Méd Interne 19 1998 819 822
14. Montalescot G Les nouveaux antithrombotiques en pathologie coronaire Rev Méd Interne 18 1997 450 459
15. Tardy-Poncet B Mahul P Beraud A Favre J Tardy B Guyotat D Failure of Orgaran therapy in a patient with a previous heparin-induced thrombocytopenia syndrome [Correspondence] Br J Haematol 90 1995 669 670